Fruit and menthol e-cigarette flavors drive use among teens, Indonesian study finds

The associations between sensation-seeking behavior and electronic cigarette (e-cigarette) use.

MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win

Clesrovimab is a single dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Image credit: Sergiy Palamarchuk / Shutterstock.

October 18, 2024

PROs Support Practice-Changing RUBY Trial in Endometrial Cancer

The buzz created by two phase III studies testing immunotherapy in advanced or recurrent endometrial cancer at the Society of Gynecologic Oncology (SGO) annual meeting

June 21, 2023

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024 – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Monthly Figures DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.